Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training? [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether dapagliflozin enhances adaptation to endurance exercise training; completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Christopher Bell | Conditions: Physical Activity | Phase 2 | Status: COMPLETED | Results posted: 2019-04-10